Josep M. Llovet

Institució Catalana de Recerca i Estudis Avançats

Also affiliated with Breast Cancer Research Foundation, Departament de Salut, Mount Sinai Hospital, Fundació Clínic per a la Recerca Biomèdica, Consorci Institut D'Investigacions Biomediques August Pi I Sunyer, Universitat de Barcelona, Icahn School of Medicine at Mount Sinai

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 40 papers. Top paper: “Molecular characterisation of hepatocellular carcinoma in patients with non-alcoholic steatohepatitis”.

Molecular characterisation of hepatocellular carcinoma in patients with non-alcoholic steatohepatitis

Journal of Hepatology(2021)10.1016/j.jhep.2021.04.049

N/A

8.4DataRank · unranked

236 citations

Sara Torrecilla, Huan Wang, Carla Montironi, Marta Piqué‐Gili, Miguel Torres‐Martín +30 more

CXCR2 inhibition enables NASH-HCC immunotherapy

Gut(2022)10.1136/gutjnl-2021-326259

N/A

4.8DataRank · unranked

230 citations

John B. G. Mackey, Thomas Jamieson, Erik Ramon‐Gil, Thomas M. Drake, Frédéric Fercoq +41 more

Promotion of cholangiocarcinoma growth by diverse cancer-associated fibroblast subpopulations

Cancer Cell(2021)10.1016/j.ccell.2021.03.012

N/A

0.903DataRank · unranked

410 citations

Ajay Nair, Francesco Brundu, Aashreya Ravichandra, Sonakshi Bhattacharjee, Michitaka Matsuda +32 more

Intratumoral heterogeneity and clonal evolution in liver cancer

Nature Communications(2020)10.1038/s41467-019-14050-z

N/A

0.885DataRank · unranked

365 citations

Amanda J. Craig, Carlos Villacorta-Martín, Sebastião N. Martins-Filho, Nicholas K. Akers, Xintong Chen +23 more

Adjuvant and neoadjuvant immunotherapies in hepatocellular carcinoma

Nature Reviews Clinical Oncology(2024)10.1038/s41571-024-00868-0

N/A

0.883DataRank · unranked

359 citations

Roser Pinyol, Mark Yarchoan, Amit G. Singal, Thomas U. Marron, Myron E. Schwartz +4 more

Immunomodulatory Effects of Lenvatinib Plus Anti–Programmed Cell Death Protein 1 in Mice and Rationale for Patient Enrichment in Hepatocellular Carcinoma

Hepatology(2021)10.1002/hep.32023

N/A

0.767DataRank · unranked

165 citations

Carla Montironi, Marc Puigvehí, Agavni Mesropian, Jack Leslie, Philipp K. Haber +15 more

Unannotated small RNA clusters associated with circulating extracellular vesicles detect early stage liver cancer

Gut(2021)10.1136/gutjnl-2021-325036

N/A

0.626DataRank · unranked

64 citations

Teresa García‐Lezana, Navneet Dogra, Edgar Gonzalez‐Kozlova, Mehmet Eren Ahsen, Amanda J. Craig +27 more

Single-cell RNA sequencing-derived signatures define response patterns to atezolizumab + bevacizumab in advanced hepatocellular carcinoma

Journal of Hepatology(2024)10.1016/j.jhep.2024.12.016

N/A

0.596DataRank · unranked

52 citations

Marta Piqué‐Gili, Roger Esteban-Fabró, Gino Philips, Ugne Balaseviciute, Roser Pinyol +36 more

WNTinib is a multi-kinase inhibitor with specificity against β-catenin mutant hepatocellular carcinoma

Nature Cancer(2023)10.1038/s43018-023-00609-9

N/A

0.505DataRank · unranked

28 citations

Mary E. Duffy, Alex P. Scopton, Frank Fonseca, Julia N. Zhao, Megan Schwarz +30 more

Two decades of advances in clinical oncology — lessons learned and future directions

Nature Reviews Clinical Oncology(2024)10.1038/s41571-024-00945-4

N/A

0.477DataRank · unranked

23 citations

Christopher M. Booth, Éduardo Bruera, Markus W. Büchler, Alexander Drilon, Terry J. Fry +14 more

Epidermal Growth Factor Receptor Inhibition With Erlotinib in Liver: Dose De-Escalation Pilot Trial as an Initial Step in a Chemoprevention Strategy

Gastro Hep Advances(2024)10.1016/j.gastha.2024.01.009

N/A

0.365DataRank · unranked

6 citations

David M. Zahrieh, Carrie Strand, Yujin Hoshida, Thomas J. Flotte, Gary Della’Zanna +9 more

Strategies to address non-proportional hazards between survival curves - Lessons from phase III trials in hepatocellular carcinoma

Journal of Hepatology(2025)10.1016/j.jhep.2025.08.042

N/A

0.345DataRank · unranked

9 citations

Tiago de Castro, Marcus Zeitlhoefler, Allan Hackshaw, MinJae Lee, Tim Meyer +3 more

Oncogenic role of PMEPA1 and its association with immune exhaustion and TGF-β activation in HCC

JHEP Reports(2024)10.1016/j.jhepr.2024.101212

N/A

0.292DataRank · unranked

6 citations

Carmen Andreu-Oller, Agavni Mesropian, Roger Esteban-Fabró, Marina Bárcena‐Varela, Marina Ruiz de Galarreta +19 more

E7386 Enhances Lenvatinib’s Antitumor Activity in Preclinical Models and Human Hepatocellular Carcinoma

Clinical Cancer Research(2025)10.1158/1078-0432.ccr-25-0725

N/A

0.282DataRank · unranked

5 citations

Albert Gris‐Oliver, Ugne Balaseviciute, Alka A. Potdar, Takayuki Kimura, Jialing Shen +21 more

CXCR2 inhibition enables NASH-HCC immunotherapy

bioRxiv (Cold Spring Harbor Laboratory)(2022)10.1101/2022.02.24.481779

N/A

0.275DataRank · unranked

3 citations

John B. G. Mackey, Thomas Jamieson, Erik Ramon‐Gil, Thomas M. Drake, Frédéric Fercoq +41 more

Artificial intelligence predicts outcome-related molecular profiles and vascular invasion in hepatocellular carcinoma

JHEP Reports(2025)10.1016/j.jhepr.2025.101592

N/A

0.241DataRank · unranked

4 citations

Agavni Mesropian, Laura Žigutytė, James Brooks, Ezequiel Mauro, Albert Gris‐Oliver +13 more

Data from Cabozantinib Enhances Anti-PD1 Activity and Elicits a Neutrophil-Based Immune Response in Hepatocellular Carcinoma

(2023)10.1158/1078-0432.c.6530994.v1

N/A

0DataRank · unranked

0 citations

Catherine E. Willoughby, Marta Piqué‐Gili, Carla Montironi, Jordi Abril‐Fornaguera, Judit Peix +8 more

Neoadjuvant atezolizumab plus bevacizumab prior liver transplantation for hepatocellular carcinoma

JHEP Reports(2024)10.1016/j.jhepr.2024.101246

N/A

0DataRank · unranked

21 citations

Rebecca Marino, Sherrie Bhoori, Marcus Zeitlhoefler, Neil Mehta, Vanessa Banz +8 more

Hepatocellular carcinoma hosts cholinergic neural cells and tumoral hepatocytes harboring targetable muscarinic receptors

JHEP Reports(2024)10.1016/j.jhepr.2024.101245

N/A

0DataRank · unranked

8 citations

Claire Verzeroli, Armando Andres Roca Suarez, Abud-José Farca-Luna, Laurie Tonon, Roger Esteban-Fabró +20 more

Hepatocellular carcinoma: Epidemiology, diagnosis and treatment

JHEP Reports(2025)10.1016/j.jhepr.2025.101571

N/A

0DataRank · unranked

52 citations

Tiago de Castro, Marcus Zeitlhoefler, Max W. Sung, Augusto Villanueva, Vincenzo Mazzaferro +2 more

Clinical Feasibility of Circulating Tumor DNA in Patients with Advanced Hepatocellular Carcinoma Treated with Atezolizumab plus Bevacizumab

Liver Cancer(2025)10.1159/000549565

N/A

0DataRank · unranked

2 citations

Dong Jun Shin, Beodeul Kang, Haeyoun Kang, Sung Hwan Lee, Jung Sun Kim +10 more

Molecular insights into early malignant transition of hepatocellular carcinoma

bioRxiv (Cold Spring Harbor Laboratory)(2025)10.1101/2025.04.14.648739

N/A

0DataRank · unranked

0 citations

H. Li, Lingli Chen, Tao Lü, Xinyi Shentu, Yuanhua Liu +15 more

Spatial immune scoring and prediction of HCC outcomes

JHEP Reports(2025)10.1016/j.jhepr.2025.101476

N/A

0DataRank · unranked

0 citations

Daniela Sia, Josep M. Llovet

Trial Design and Endpoints in Hepatocellular Carcinoma: AASLD Consensus Conference

Hepatology(2020)10.1002/hep.31327

N/A

0DataRank · unranked

414 citations

Augusto Villanueva, Jorge A. Marrero, Myron E. Schwartz, Tim Meyer, Peter R. Galle +9 more

Effective therapeutic targeting of CTNNB1 ‐mutant hepatoblastoma with WNTinib

Molecular Oncology(2025)10.1002/1878-0261.70168

N/A

0DataRank · unranked

0 citations

Júlia Huguet‐Pradell, Jordi Abril‐Fornaguera, Albert Gris‐Oliver, Alex Rialdi, Elisa Fernández‐Martínez +13 more

Liver Injury Increases the Incidence of HCC following AAV Gene Therapy in Mice

Molecular Therapy(2020)10.1016/j.ymthe.2020.10.018

N/A

0DataRank · unranked

104 citations

Laura Torrens, Jordi Abril‐Fornaguera, Roser Pinyol, Catherine E. Willoughby, Jeffrey Posey +6 more

Intratumoral heterogeneity and clonal evolution in liver cancer

immuneACCESS(2020)10.21417/bl2020nc

N/A

0DataRank · unranked

18 citations

Craig Aj, C Villacorta-Martin, SN Martins-Filho, N Akers, Xin-Wen CHEN +23 more

Unannotated small RNA clusters in circulating extracellular vesicles detect early stage liver cancer

bioRxiv (Cold Spring Harbor Laboratory)(2020)10.1101/2020.04.29.066183

N/A

0DataRank · unranked

3 citations

Teresa Garcia-Lezana, Navneet Dogra, Edgar Gonzalez‐Kozlova, Mehmet Eren Ahsen, Amanda J. Craig +27 more

MicroRNA-Based Classification of Hepatocellular Carcinoma and Oncogenic Role of miR-517a

UNC Libraries(2020)10.17615/0mn5-xx04

N/A

0DataRank · unranked

0 citations

Vincenzo Mazzaferro, Todd R. Golub, Derek Y. Chiang, Samuel Waxman, Stephen C. Ward +15 more

International Liver Cancer Association (ILCA) White Paper on Biomarker Development for Hepatocellular Carcinoma

Gastroenterology(2021)10.1053/j.gastro.2021.01.233

N/A

0DataRank · unranked

159 citations

Yujin Hoshida, David J. Pinato, Jorge A. Marrero, Jean‐Charles Nault, Valérie Paradis +10 more

Transcriptomic characterization of cancer-testis antigens identifies MAGEA3 as a driver of tumor progression in hepatocellular carcinoma

PLoS Genetics(2021)10.1371/journal.pgen.1009589

N/A

0DataRank · unranked

32 citations

Teresa García‐Lezana, Marina Ruiz de Galarreta, Carlos Villacorta-Martín, Edgar Gonzalez‐Kozlova, Sebastião N. Martins-Filho +14 more

Molecular pathogenesis and systemic therapies for hepatocellular carcinoma

Nature Cancer(2022)10.1038/s43018-022-00357-2

N/A

0DataRank · unranked

490 citations

Roser Pinyol, Robin Kate Kelley, Anthony B. El-Khoueiry, Helen L. Reeves, Sophie Wang +3 more

Novel microenvironment-based classification of intrahepatic cholangiocarcinoma with therapeutic implications

Gut(2022)10.1136/gutjnl-2021-326514

N/A

0DataRank · unranked

143 citations

Benjamin Kepecs, Miguel Torres‐Martín, Emily R. Bramel, Philipp K. Haber, Elliot Merritt +20 more

Cabozantinib Enhances Anti-PD1 Activity and Elicits a Neutrophil-Based Immune Response in Hepatocellular Carcinoma

Clinical Cancer Research(2022)10.1158/1078-0432.ccr-21-2517

N/A

0DataRank · unranked

78 citations

Catherine E. Willoughby, Marta Piqué-Gili, Carla Montironi, Jordi Abril‐Fornaguera, Judit Peix +8 more

Hepatocellular Carcinoma in Mongolia Delineates Unique Molecular Traits and a Mutational Signature Associated with Environmental Agents

Clinical Cancer Research(2022)10.1158/1078-0432.ccr-22-0632

N/A

0DataRank · unranked

15 citations

Marc Puigvehí, Miguel Torres‐Martín, Huan Wang, Miho MAEDA, Philipp K. Haber +25 more

Combination Therapies for Advanced Hepatocellular Carcinoma: Biomarkers and Unmet Needs

Clinical Cancer Research(2022)10.1158/1078-0432.ccr-22-1213

N/A

0DataRank · unranked

8 citations

Josep M. Llovet, Sarah Cappuyns

Critical Appraisal of Guideline Recommendations on Systemic Therapies for Advanced Hepatocellular Carcinoma

JAMA Oncology(2023)10.1001/jamaoncol.2023.2677

N/A

0DataRank · unranked

151 citations

Virginia Corbett, Mark Yarchoan, Richard S. Finn, Josep M. Llovet, Sarah Cappuyns

Identification of IGF2 as Genomic Driver and Actionable Therapeutic Target in Hepatoblastoma

Molecular Cancer Therapeutics(2023)10.1158/1535-7163.mct-22-0335

N/A

0DataRank · unranked

15 citations

Laura Torrens, Carmen Andreu-Oller, Juan Carrillo-Reixach, Alexander Rialdi, Ugne Balaseviciute +24 more

Supplementary Figure from Cabozantinib Enhances Anti-PD1 Activity and Elicits a Neutrophil-Based Immune Response in Hepatocellular Carcinoma

INDIGO (University of Illinois at Chicago)(2023)10.1158/1078-0432.22482765.v1

N/A

0DataRank · unranked

0 citations

Catherine E. Willoughby, Marta Piqué‐Gili, Carla Montironi, Jordi Abril‐Fornaguera, Judit Peix +8 more

Data from Cabozantinib Enhances Anti-PD1 Activity and Elicits a Neutrophil-Based Immune Response in Hepatocellular Carcinoma

(2023)10.1158/1078-0432.c.6530994

N/A

0DataRank · unranked

0 citations

Catherine E. Willoughby, Marta Piqué‐Gili, Carla Montironi, Jordi Abril‐Fornaguera, Judit Peix +8 more